Qi B, Chen Y, Chai S, Lu X, et al. O-linked beta-N-acetylglucosamine (O-GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy. Diabet Med 2024 Sep 16:e15436. doi: 10.1111/dme.15436.
PMID: 39279604